TITLE

Effects of Human Immunodeficiency Virus Infection on Recurrence of Tuberculosis after Rifampin-Based Treatment: An Analytical Review

AUTHOR(S)
Korenromp, Eline L.; Scano, Fabio; Williams, Brian G.; Dye, Christopher; Nunn, Paul
PUB. DATE
July 2003
SOURCE
Clinical Infectious Diseases;7/1/2003, Vol. 37 Issue 1, p101
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We reviewed 47 prospective studies of recurrence of pulmonary tuberculosis (TB) after cure to assess the influence of human immunodeficiency virus (HIV) infection and rifampin treatment. Multivariate regression revealed that the recurrence rate for HIV-uninfected persons increased with decreasing duration of therapy: it was 1.4 cases per 100 person-years for recipients of ⩾ 7 months of rifampin therapy and 2.0 and 4.0 cases per 100 person-years for recipients of 5-6 and 2-3 months of rifampin therapy, respectively (trend P = .00014), over a mean follow-up duration of 34 months, at a TB incidence of 250 cases per 100,000 person-years. Relative risks of recurrence associated with HIV infection at these 3 treatment durations were 2.2, 2.1, and 3.4, respectively, with a significant interaction between HIV infection status and treatment duration (P = .025). The recurrence rate increased with the background TB incidence (P = .048), and it decreased over time since completion of treatment in HIV-uninfected but not in HIV-infected patients (overall trend, P = .00008; difference by HIV infection status, P = .025). In countries where HIV infection is endemic, TB recurrence may be reduced by administration of rifampin-based treatment for at least 6 months, in accordance with World Health Organization recommendations.
ACCESSION #
10361855

 

Related Articles

  • Preventing Relapse of Tuberculosis. Deresinski, Stan // Clinical Infectious Diseases;2/15/2007, Vol. 44 Issue 4, pv 

    The article presents information on a study concerning the relapse of tuberculosis after completion of standard treatment regimens. Standard tuberculosis treatment includes rifampin. Factors that may cause relapse include the presence of cavitary disease and a positive 2-month sputum culture....

  • Impact of HIV Infection on the Recurrence of Tuberculosis in South India. Narayanan, Sujatha; Swaminathan, Soumya; Supply, Philip; Shanmugam, Sivakumar; Narendran, Gopalan; Hari, Lalitha; Ramachandran, Ranjani; Locht, Camille; Jawahar, Mohideen Shaheed; Narayanan, Paranji Raman // Journal of Infectious Diseases;3/1/2010, Vol. 201 Issue 5, p691 

    Background. There is limited information on the relative proportion of reactivation and reinfection at the time of recurrence among human immunodeficiency virus (HIV)-infected and HIV-uninfected patients who are successfully treated for tuberculosis infection in India. Methods. HIV-infected and...

  • TB regimen revised.  // Patient Care;Oct2003, Vol. 37 Issue 10, p3 

    Reports that the American Thoracic Society and the U.S. Center for Disease Control has revised its recommendations against the use of rifampin and pyrazinamide for treatment of tuberculosis infection in HIV-negative and HIV-infected patients. Diseases associated with rifampin and pyrazinamide...

  • Ritonavir Enables Combined Therapy with Rifampin and Saquinavir. Veldkamp, A .I.; Hoetelmans, R. M. W.; Beijnen, J. H.; Mulder, J. W.; Meenhorst, P. L. // Clinical Infectious Diseases;12/1/1999, Vol. 29 Issue 6, p1586 

    Examines whether ritonavir enables the treatment of coinfection by HIV-1 and Mycobacterium tuberculosis with saquinavir and rifampin. Standard of care for the treatment of HIV-1 infection; Pharmacokinetic profiles of saquinavir in patients treated with combinations of ritonavir, saquinavir and...

  • The incidence of recurrence of tuberculosis and its related factors in smear-positive pulmonary tuberculosis patients in Iran: A retrospective cohort study. Moosazadeh, Mahmood; Bahrampour, Abbas; Nasehi, Mahshid; Khanjani, Narges // Lung India;Nov/Dec2015, Vol. 32 Issue 6, p557 

    Background and Aim: Studying the recurrence of smear-positive pulmonary tuberculosis (TB) is a convenient way to evaluate the effectiveness of TB control programs and identify vulnerable patients. In the present study, the rate of recurrence of TB and its predictors were determined in Iran....

  • Peak plasma rifampicin level in tuberculosis patients with slow culture conversion. Chang, K.-C.; Leung, C.-C.; Yew, W.-W.; Kam, K.-M.; Yip, C.-W.; Ma, C.-H.; Tam, C.-M.; Leung, E.; Law, W.-S.; Leung, W.-M. // European Journal of Clinical Microbiology & Infectious Diseases;Jun2008, Vol. 27 Issue 6, p467 

    The clinical utility of therapeutic drug monitoring in tuberculosis has not been adequately evaluated by controlled clinical trials. To examine the relationship between slow culture conversion and peak plasma rifampicin level (Cmax-rfm) in a case-control study, patients with persistence of...

  • Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria. Aliyu, Gambo; El-Kamary, Samer S.; Abimiku, Alash'le; Ezati, Nicholas; Mosunmola, Iwakun; Hungerford, Laura; Brown, Clayton; Tracy, Kathleen J.; Obasanya, Joshua; Blattner, William // Tuberculosis Research & Treatment;2013, p1 

    Objective. Data on pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) complex in Nigeria are limited. We investigated species of MTB complex in TB cases from northern Nigeria. Methods. New TB suspects were enrolled, screened for HIV and their sputum samples were cultured...

  • Late onset Warfarin induced skin necrosis in human immunodeficiency virus infected patient with pulmonary tuberculosis. Choudhary, Sanjiv Vijay; Madnani, Amrita; Singh, A. L. // Indian Journal of Sexually Transmitted Diseases;Jan-Jun2013, Vol. 34 Issue 1, p47 

    The incidence of Warfarin-induced skin necrosis (WISN) is very low 0.01-0.10%. The majority of the WISN cases appear between day 3 and 6 of onset of Warfarin therapy. The cases of late onset WISN are rarely seen. We report a case of late onset WISN in a young human immunodeficiency virus...

  • Associated Factors for Tuberculosis Recurrence in Taiwan: A Nationwide Nested Case-Control Study from 1998 to 2010. Hung, Chung-Lin; Chien, Jung-Yien; Ou, Chih-Ying // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: The contribution of human immunodeficiency virus (HIV) co-infection to tuberculosis (TB) recurrence is well established worldwide. We conducted this study to investigate associated factors for recurrent TB in Taiwan, which has a relatively low prevalence of HIV. Methods: A...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics